We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,306.00
Bid: 2,306.00
Ask: 2,308.00
Change: -33.00 (-1.41%)
Spread: 2.00 (0.09%)
Open: 2,325.00
High: 2,393.00
Low: 2,306.00
Yest. Close: 2,339.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Broker tips: Johnston Press, Direct Line, Hikma Pharmaceuticals

(ShareCast News) - Johnston Press shares plunged on Thursday as Numis placed its rating and target price 'under review' after the company swung to a first half loss. For the 26 weeks to 2 July, the company posted a statutory pre-tax loss of £183.7m versus a £2.2m profit the year before, as it booked

4 Aug 16 11:01

Citi downgrades Hikma Pharmaceuticals after company´s pre-announcement

(ShareCast News) - Analysts at Citi downgraded their recommendation on shares of Hikma Pharmaceuticals in the wake of the company´s trading update which was issued after the close of trading in London on 3 August. Hikma flagged new drug approvals were arriving more slowly than expected and the phasi

4 Aug 16 09:59

Hikma Pharmaceuticals warns generic drug delays will lower profit

(ShareCast News) - Shares in Hikma Pharmaceuticals plummeted on Thursday after the drugmaker's overnight warning that delays to new US generic products would lower profits. In a trading update for the first six months of the year that was released almost an hour after the London stock market closed

4 Aug 16 09:12

FTSE steadies near 3-week low before BoE decision, Hikma sinks

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 steady in morning trade * Focus on BoE's rate decision * Hikma slumps after update By Atul Prakash LONDON,

4 Aug 16 09:01

BROKER RATINGS SUMMARY: RBC Upgrades G4S But Barclays Downgrades It

25 Jul 16 08:27

Hikma says colchicine regulatory approval upheld in US Court of Appeals

(ShareCast News) - Hikma Pharmaceuticals on Thursday said the regulatory approval of its gout medication colchicine has been upheld. The US Court of Appeals for the District of Columbia Circuit affirmed an earlier decision of the US District Court for the District of Columbia, finding in fa

21 Jul 16 09:11

Regulatory Approval Of Hikma's Colchicine Capsule Upheld By US Court

21 Jul 16 06:52

Britain's FTSE climbs to 11-month closing high as insurers rise

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 rises 0.5 pct to 6,728.99 points * Healthcare stocks among top gainers * Admiral Group rises after upgrade, L&G up as

20 Jul 16 16:20

Hikma Pharmaceuticals launches generic cancer tablets in US

(ShareCast News) - Hikma Pharmaceuticals said its wholly-owned US affiliate, West-Ward Pharmaceuticals has launched generic cancer treatment tablets in the US. The Capecitabine tablets, which are the generic equivalents to Xeloda tablets, are indicated for adjuvant treatment in patients with Dukes'

20 Jul 16 11:54

WINNERS & LOSERS SUMMARY: Man Group Down As CEO Departs For PIMCO

20 Jul 16 09:47

Britain's FTSE rallies though miners lag

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 up 0.4 pct * Healthcare stocks among top gainers * Admiral Group rises after upgrade * Miners fall on disappoint

20 Jul 16 09:14

LONDON MARKET OPEN: Stocks Mixed As Miners Limit FTSE 100 Gains

20 Jul 16 07:33

TOP NEWS: Hikma Pharmaceuticals Launches Xeloda Tablets In US

20 Jul 16 06:42

BROKER RATINGS SUMMARY: HSBC Downgrades Hikma To Hold From Buy

11 Jul 16 08:40

LONDON MARKET OPEN: RPC Profit Comes Ahead Of Its Expectations

11 Jul 16 07:33

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.